| Application | Comment | Organism |
|---|---|---|
| degradation | new tryptophan catabolic pathway in Burholderia cepacia J2315, formation of the intermediate 4-oxalocrotonate differentiates this pathway from the proposed mammalian pathway which converts 2-aminomuconate to 2-ketoadipate and, ultimately, glutaryl-coenzyme A | Burkholderia cepacia |
| Cloned (Comment) | Organism |
|---|---|
| cloned into plasmid pDESTF1 and overexpressed in Escherichia coli Tuner (DE3) | Burkholderia cepacia |
| Molecular Weight [Da] | Molecular Weight Maximum [Da] | Comment | Organism |
|---|---|---|---|
| 18000 | - |
overexpressed soluble protein | Burkholderia cepacia |
| Organism | UniProt | Comment | Textmining |
|---|---|---|---|
| Burkholderia cepacia | - |
- |
- |
| Burkholderia cepacia J2315 | - |
- |
- |
| Purification (Comment) | Organism |
|---|---|
| by nickel-nitrilotriacetic acid affinity chromatography | Burkholderia cepacia |
| Substrates | Comment Substrates | Organism | Products | Comment (Products) | Rev. | Reac. |
|---|---|---|---|---|---|---|
| 2-aminomuconate + H2O | - |
Burkholderia cepacia | 4-oxalocrotonate + NH3 | - |
? | |
| 2-aminomuconate + H2O | - |
Burkholderia cepacia J2315 | 4-oxalocrotonate + NH3 | - |
? |
| Synonyms | Comment | Organism |
|---|---|---|
| 2-aminomuconate deaminase | - |
Burkholderia cepacia |
| AMD | - |
Burkholderia cepacia |